Autologous CAR-T Cell Manufacturing: Current Standing and Future Directions
A Look at What Drug Manufacturers are Likely Using to Make CAR-T Products
Supplement: MilliporeSigma Sees Opportunity in Continuous Processing
From the GEN Sounds of Science Podcast
Why CAR-T Therapies Don’t Work for Everyone Yet
Selecting the Best Type of T Cells for CAR-T May be Key to the Overall Efficacy of the Therapies
Cell-Centered: Scientists Embrace Cell-Replacement Therapy for Type 1 Diabetes
Forming Beta Cells from Stem Cells
For full access to this article login to GEN Select now.
Supplement: Immunotherapy Encompasses More Than Immuno-oncology
The Future of Medicine Lies in Treatments that Work in Concert with the Body’s Immune System
- Immuno-oncology has stolen the spotlight, but it is just one aspect of immunotherapy, one of the hottest trends in biopharma. According to Sapna Jha, a lead healthcare and life sciences analyst from Technavio, a market research company, cancer immunotherapies offer “better efficacy, enhanced safety, and higher patient adherence ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.